Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

LBL 2018 - International Cooperative Treatment Protocol for Children and Adolescents With Lymphoblastic Lymphoma

NCT04043494 is registered in ClinicalTrials.gov with University Hospital Muenster as lead sponsor.

NCT NCT04043494
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04043494 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
LBL 2018 - International Cooperative Treatment Protocol for Children and Adolescents With Lymphoblastic Lymphoma
Lead sponsor
University Hospital Muenster
Phase
Phase 3
Overall status
Recruiting
Start date
August 23, 2019
Completion date
April 22, 2030
Enrollment
683 (estimated)
Sites
228

Conditions

As the registry lists them; a condition with its own page is linked.

lymphoblastic lymphoma, childhood